Autoimmunity Reviews

Papers
(The H4-Index of Autoimmunity Reviews is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The SARS-CoV-2 as an instrumental trigger of autoimmunity379
Rheumatoid arthritis: Extra-articular manifestations and comorbidities224
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis175
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases174
The influence of cytokines on the complex pathology of ulcerative colitis157
Post-COVID syndrome. A case series and comprehensive review149
SARS-CoV-2, the autoimmune virus148
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis133
An updated advance of autoantibodies in autoimmune diseases116
CCR6-CCL20 axis as a therapeutic target for autoimmune diseases113
An Overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions108
Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: Potential role in Sjögren’s syndrome105
B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)104
Novel insights into macrophage diversity in rheumatoid arthritis synovium90
The autonomic aspects of the post-COVID19 syndrome81
Rheumatological complications of Covid 1978
The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis74
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease73
Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis71
Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies64
Neuropsychiatric involvement in systemic lupus erythematosus: A review63
The role of T cells in pemphigus vulgaris and bullous pemphigoid62
Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review61
Eosinophilic granulomatosis with polyangiitis: A review54
Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data54
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets53
Mucous membrane pemphigoid52
Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: A systemic review and meta-analysis51
Autoantibodies in COVID-19: frequency and function51
Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis50
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus49
Autoimmune pre-disease48
Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”48
The roles of adenosine deaminase in autoimmune diseases47
“Non-criteria” antiphospholipid syndrome: A nomenclature proposal46
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus45
Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis45
Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials44
Update in immunosuppressive therapy of myasthenia gravis44
Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review44
Seronegative autoimmune diseases: A challenging diagnosis44
Phoenix from the flames: Rediscovering the role of the CD40–CD40L pathway in systemic lupus erythematosus and lupus nephritis43
Pentraxin 3: A promising therapeutic target for autoimmune diseases43
0.062664031982422